logo

COGT Stock on the Rise: A Promising Investment

PNC Stock

In terms of market performance, Cogent Biosciences Inc had a fairly uneven. The highest value for the stock in the past year was $12.61 on 10/23/24, and the lowest value was recorded at $3.72 on 04/09/25.

52-week price history of COGT Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Cogent Biosciences Inc’s current trading price is -62.73% away from its 52-week high, while its distance from the 52-week low is 26.34%. The stock’s price range during this period has spanned from $3.72 to $12.61. In the Healthcare sector, the Cogent Biosciences Inc’s shares surpassed a trading volume of approximately 1.23 million for the day, which was noticeably lower compared to the average daily volume of 9.1.38 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Cogent Biosciences Inc (COGT) has experienced a quarterly decline of -49.19% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 535.12M and boasts a workforce of 205 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 7.12, with a change in price of -4.97. Similarly, Cogent Biosciences Inc recorded 1,435,305 in trading volume during the last 100 days, posting a change of -51.40%.

Examining COGT’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for COGT stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.

COGT Stock Stochastic Average

Today, Cogent Biosciences Inc’s raw stochastic average for the past 50 days stands at 23.61%, indicating a decline from the raw stochastic average of the last 20 days, which was 45.16%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 76.50% and 86.59% respectively.

COGT Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -39.74%. However, over the past six months, we’ve seen a stronger performance of -59.09%. The price of COGT leaped by -1.47% over the last 30 days. And in the last five days, it has fallen by -6.37%.